Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(9%)
Results Posted
40%(2 trials)

Phase Distribution

Ph phase_4
2
18%
Ph phase_2
2
18%
Ph not_applicable
3
27%
Ph phase_3
2
18%
Ph phase_1
2
18%

Phase Distribution

2

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
2(18.2%)
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
2(18.2%)
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
3(27.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(5)
Terminated(1)
Other(3)

Detailed Status

Completed5
unknown3
Recruiting1
Withdrawn1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (18.2%)
Phase 22 (18.2%)
Phase 32 (18.2%)
Phase 42 (18.2%)
N/A3 (27.3%)

Trials by Status

recruiting19%
withdrawn19%
enrolling_by_invitation19%
completed545%
unknown327%

Recent Activity

1 active trials
Showing 5 of 11
enrolling_by_invitationphase_4

Imaging Biomarkers of Pancreatic Function and Disease

NCT05659147
recruitingphase_3

The Cancer of the Pancreas Screening-5 CAPS5)Study

NCT02000089
unknownphase_3

Aspiration of Duodenopancreatic Juice After Secretin Stimulation vs Endoscopic Aspiration for Molecular Analysis of Intraductal Papillary Mucinous Intraductal Neoplasia.

NCT05914077
completednot_applicable

The Role of Secretin on the Energy Homeostasis

NCT04613700
completednot_applicable

MRCP: A Reliable, Non Invasive Method for Staging Chronic Pancreatitis in Pediatrics

NCT02869893
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT05659147Phase 4

Imaging Biomarkers of Pancreatic Function and Disease

Enrolling By Invitation
NCT02000089Phase 3

The Cancer of the Pancreas Screening-5 CAPS5)Study

Recruiting
NCT05914077Phase 3

Aspiration of Duodenopancreatic Juice After Secretin Stimulation vs Endoscopic Aspiration for Molecular Analysis of Intraductal Papillary Mucinous Intraductal Neoplasia.

Unknown
NCT04613700Not Applicable

The Role of Secretin on the Energy Homeostasis

Completed
NCT02869893Not Applicable

MRCP: A Reliable, Non Invasive Method for Staging Chronic Pancreatitis in Pediatrics

Completed
NCT02160808Phase 2

Secretin Infusion to Prevent Pancreatic Leaks Following Pancreatic Resection

Completed
NCT03686618Phase 2

Secretin for Acute Pancreatitis

Unknown
NCT01094626Not Applicable

Secretin-enhanced Magnetic Resonance Imaging (S-MRI) for Pancreatic Cancer Detection

Withdrawn
NCT02458118Phase 1

Pancreatic Perfusion Using Secretin and MRI

Unknown
NCT01452217Phase 1

Non-invasive MRI to Quantify the Effect of Secretin on Pancreatic Blood Flow and Perfusion in Healthy Volunteers

Completed
NCT01134848Phase 4

A Study of Serial Magnetic Resonance Cholangiopancreatography (MRCP) Following Morphine-neostigmine and Secretin Provocation in Healthy Volunteers

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11